Literature DB >> 33472227

Late Bacterial Endocarditis in an Intravenous Drug User With an Amplatzer Septal Occluder.

Michael S La Sala1, Hajir Zohourian2, Joseph McKeown3, Samuel Snyder1.   

Abstract

Infective endocarditis of a fully endothelialized cardiac prosthesis, and especially the late presentation of endocarditis, challenges our current understanding of device-related complications. Late bacterial endocarditis associated with the Amplatzer Septal Occluder, a device frequently used to close atrial septal defects, has been documented only rarely. We report the case of an intravenous drug user who had late infective endocarditis associated with his Amplatzer Septal Occluder, secondary to methicillin-sensitive Staphylococcus aureus bacteremia nearly 14 years after device insertion. The patient recovered after surgical excision and débridement of the vegetative mass, which may be the first time that a surgical approach has been taken to treat this condition. This report corroborates the need for late screening of high-risk patients who have septal occluder devices.
© 2020 by the Texas Heart® Institute, Houston.

Entities:  

Keywords:  Cardiac surgical procedures; endocarditis, bacterial/complications/diagnosis/etiology; heart septal defects, atrial/pathology; prostheses and implants; prosthesis-related infections/diagnosis/surgery; risk factors; septal occluder devices/adverse effects; treatment outcome

Mesh:

Year:  2020        PMID: 33472227      PMCID: PMC7819446          DOI: 10.14503/THIJ-18-6903

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN: 0730-2347


  15 in total

1.  Transvenous atrial septal defect occlusion by the buttoned device.

Authors:  E B Sideris; S E Sideris; B D Thanopoulos; R L Ehly; J P Fowlkes
Journal:  Am J Cardiol       Date:  1990-12-15       Impact factor: 2.778

2.  Trends in infective endocarditis incidence, microbiology, and valve replacement in the United States from 2000 to 2011.

Authors:  Sadip Pant; Nileshkumar J Patel; Abhishek Deshmukh; Harsh Golwala; Nilay Patel; Apurva Badheka; Glenn A Hirsch; Jawahar L Mehta
Journal:  J Am Coll Cardiol       Date:  2015-05-19       Impact factor: 24.094

3.  2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.

Authors:  Rick A Nishimura; Catherine M Otto; Robert O Bonow; Blase A Carabello; John P Erwin; Robert A Guyton; Patrick T O'Gara; Carlos E Ruiz; Nikolaos J Skubas; Paul Sorajja; Thoralf M Sundt; James D Thomas
Journal:  Circulation       Date:  2014-03-03       Impact factor: 29.690

Review 4.  Infective endocarditis after device closure of atrial septal defects: Case report and review of the literature.

Authors:  Pascal Amedro; Camille Soulatges; Alain Fraisse
Journal:  Catheter Cardiovasc Interv       Date:  2016-09-19       Impact factor: 2.692

5.  Endocarditis and Incomplete Endothelialization 12 Years after Amplatzer Septal Occluder Deployment.

Authors:  Allan K Nguyen; Brian A Palafox; Joanne P Starr; Richard N Gates; Farbouch Berdjis
Journal:  Tex Heart Inst J       Date:  2016-06-01

6.  Unconventional uses of septal occluder devices: Our experience reviewed.

Authors:  Neeraj Awasthy; Munesh Tomar; S Radhakrishnan; Savitri Shrivastava
Journal:  Indian Heart J       Date:  2015-05-14

Review 7.  Long-term Complications After Transcatheter Atrial Septal Defect Closure: A Review of the Medical Literature.

Authors:  Zakaria Jalal; Sebastien Hascoet; Alban-Elouen Baruteau; Xavier Iriart; Bernard Kreitmann; Younes Boudjemline; Jean-Benoit Thambo
Journal:  Can J Cardiol       Date:  2016-03-03       Impact factor: 5.223

8.  Inflammatory, abscess-forming foreign body reaction mimics a thrombus formation on an atrial septal defect closure device: A commented case report.

Authors:  Dimitar Divchev; Edith Katharina Podewski; Michael Mengel; Gerd Peter Meyer; Helmut Drexler; Arnd Schaefer
Journal:  Eur J Echocardiogr       Date:  2006-06-08

9.  Incomplete endothelialisation of an Amplatzer Septal Occluder device followed by meningitis and late acute bacterial endocarditis.

Authors:  Jacek Białkowski; Szymon Pawlak; Paweł Banaszak
Journal:  Cardiol Young       Date:  2015-12-28       Impact factor: 1.093

Review 10.  Current perspectives in percutaneous atrial septal defect closure devices.

Authors:  N Bissessor
Journal:  Med Devices (Auckl)       Date:  2015-07-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.